Perceived stress predicts the stability of vitamin K-antagonist treatment of anticoagulant clinic patients

Jane Skov; Anja Leppin; Else-Marie Bladbjerg; Johannes J. Sidelmann; Jørgen Gram

doi:10.1160/TH12-05-0344

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2012; 108(03): 581-582
DOI: 10.1160/TH12-05-0344

Letters to the Editor

Schattauer GmbH

Perceived stress predicts the stability of vitamin K-antagonist treatment of anticoagulant clinic patients

Jane Skov

¹Unit for Thrombosis Research, Institute of Public Health, University of Southern Denmark, Esbjerg, Denmark

,

Anja Leppin

²Unit for Health Promotion, Institute of Public Health, University of Southern Denmark, Esbjerg, Denmark

,

Else-Marie Bladbjerg

¹Unit for Thrombosis Research, Institute of Public Health, University of Southern Denmark, Esbjerg, Denmark

,

Johannes J. Sidelmann

¹Unit for Thrombosis Research, Institute of Public Health, University of Southern Denmark, Esbjerg, Denmark

,

Jørgen Gram

³Department of Clinical Biochemistry, Hospital of Southwest Denmark, Esbjerg, Denmark

› Author Affiliations

Abstract

Full Text

References

References
1 Oake N, Fergusson DA, Forster AJ. et al. Frequency of adverse events in patients with poor anticoagulation: a meta-analysis. CMAJ 2007; 176: 1589-1594.
2 Wallentin L, Yusuf S, Ezekowitz MD. et al. Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial. Lancet 2010; 376: 975-983.
3 van Walraven C, Jennings A, Oake N. et al. Effect of study setting on anticoagulation control: a systematic review and metaregression. Chest 2006; 129: 1155-1166.
4 Rose AJ, Hylek EM, Ozonoff A. et al. Patient characteristics associated with oral anticoagulation control: results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA). J Thromb Haemost 2010; 08: 2182-2191.
5 Taube J, Halsall D, Baglin T. Influence of cytochrome P-450 CYP2C9 polymorphisms on warfarin sensitivity and risk of overanticoagulation in patients on long-term treatment. Blood 2000; 96: 1816-1819.
6 Sconce E, Khan T, Mason J. et al. Patients with unstable control have a poorer dietary intake of vitamin K compared to patients with stable control of anticoagulation. Thromb Haemost 2005; 93: 872-875.
7 Hawk TL, Havrda DE. Effect of stress on international normalized ratio during warfarin therapy. Ann Pharmacother 2002; 36: 617-620.
8 Diug B, Evans S, Lowthian J. et al. The unrecognized psychosocial factors contributing to bleeding risk in warfarin therapy. Stroke 2011; 42: 2866-2871.
9 Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983; 24: 385-396.
10 Rasmussen MA, Skov J, Bladbjerg EM. et al. Multivariate analysis of the relation between diet and warfarin dose. Eur J Clin Pharmacol 2012; 68: 321-328.
11 Skov J, Bladbjerg EM, Sidelmann J. et al. Plenty of pills: polypharmacy prevails in patients of a Danish anticoagulant clinic. Eur J Clin Pharmacol 2011; 67: 1169-1174.
12 Skov J, Bladbjerg EM, Rasmussen MA. et al. Genetic, clinical and behavioral determinants of vitamin K-antagonist dose - explored through multivariable modelling and visualization. Basic Clin Pharmacol Toxicol 2012; 110: 193-198.
13 Rosendaal FR, Cannegieter SC, van der Meer FJ. et al. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993; 69: 236-239.